Key result
Activating Gi-coupled DREADDs in Cx3cr1+ myeloid cells induces arrhythmias and fatal cardiac dysfunction in mice.
Why the study?
The functional consequences of real-time changes to innate immune-cell states and manipulation of myeloid cell activity remain poorly understood.
Does acute activation of Gi-coupled DREADDs in Cx3cr1+ myeloid cells reduce cardiac function in Cx3cr1Cre mice?
Does acute activation of Gi-coupled DREADDs in Cx3cr1+ myeloid cells reduce cardiac function in Cx3cr1Cre mice?
Inhibition of Cx3cr1+ myeloid cells via Gi-DREADDs induces systemic anti-inflammatory signaling and fatal acute heart failure in mice.
Answers are grounded in this paper and cite their sources.
Alerts to off-target cardiac risks in myeloid-targeted Gi-DREADD models; leaves open relevance to human inflammatory cardiomyopathy.
Little is known about the functional consequences of real-time changes to innate immune-cell states. While chemogenetic tools have become increasingly used for probing immune-brain interactions, the consequences of manipulating myeloid cell activity states remain poorly understood. In this study, we found that acute activation of Gi-coupled DREADDs (hM4Di) in Cx3cr1⁺ myeloid cells severely suppresses cardiac function and induces a predominantly anti-inflammatory signalling state in mice. This surprising finding prompted further investigation. Using high-resolution ultrasound and electrocardiography, we show that although hM4Di-Cx3cr1⁺ mice have some reduced cardiac function already prior to intervention, activation of hM4Di in Cx3cr1+ cells markedly reduces cardiac output and ejection fraction, and induces arrhythmias and increased heart-rate variability, which are absent in Cx3cr1Cre controls. hM4Di activation leads to decreased soma size, but not number, of IBA1⁺ microglia in the hypothalamus, while sections containing nucleus of the solitary tract remained unaffected. Plasma proteomic profiling using the Olink Mouse Exploratory panel revealed increased IL-10 alongside reductions in IL-23R and CCL20, indicating a shift toward systemic anti-inflammatory signalling. Furthermore, Olink analysis revealed a complex systemic signalling profile characterized by changes in several proteins associated with extracellular matrix remodelling, vascular regulation, and cell death pathways. Collectively, these findings demonstrate that Gi-DREADD inhibition of Cx3cr1⁺ myeloid cells produce coordinated central and peripheral immune changes and causes fatal cardiac dysfunction.
No takes yet. Share an insight, caveat, or question.
Holde et al. (2026) studied this question. Acute activation of Gi-coupled DREADDs (hM4Di) in Cx3cr1+ myeloid cells vs. Cx3cr1Cre controls was evaluated on Cardiac function, systemic anti-inflammatory signalling, and microglia soma size. Acute activation of Gi-coupled DREADDs in Cx3cr1+ myeloid cells markedly reduced cardiac output and ejection fraction, induced arrhythmias, and caused fatal cardiac dysfunction in mice.
Synapse has enriched 10 related papers. Consider them for comparative context: